Zheng Zhang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Diabetic Retinopathy

Mesenchymal Stem Cells

Top Venues

Cell biology international

Stem cell research & therapy

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Guangying Cao, Chao Yang, Zhitao Jin, Hanwen Wei, Chao Xin, Chengrong Zheng, Jibing Xu, Qing Huang, Zheng Zhang, Taohong Hu
FNDC5/irisin reduces ferroptosis and improves mitochondrial dysfunction in hypoxic cardiomyocytes by Nrf2/HO-1 axis. Cell biology international 46 (5) (2022)
Hongjuan Ning, Haixu Chen, Jingyu Deng, Chun Xiao, Moyan Xu, Lina Shan, Chao Yang, Zheng Zhang
Exosomes secreted by FNDC5-BMMSCs protect myocardial infarction by anti-inflammation and macrophage polarization via NF-κB signaling pathway and Nrf2/HO-1 axis. Stem cell research & therapy 12 (1) (2021)
Jian Zou, Zeping Li, Feng Tian, Yi Zhang, Chao Xu, Jiajia Zhai, Min Shi, Guangxian Wu, Zheng Zhang, Chao Yang, Haixu Chen, Xiaomiao Li
Association between Normal Thyroid Hormones and Diabetic Retinopathy in Patients with Type 2 Diabetes. BioMed research international 2020 (2020)
Jingyu Deng, Ning Zhang, Yong Wang, Chao Yang, Yabin Wang, Chao Xin, Jinming Zhao, Zhitao Jin, Feng Cao, Zheng Zhang
FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction. Stem cell research & therapy 11 (1) (2020)
Jingyu Deng, Ning Zhang, Feng Chen, Chao Yang, Hongjuan Ning, Chun Xiao, Ke Sun, Yongfei Liu, Ming Yang, Taohong Hu, Zheng Zhang, Wei Jiang
Irisin ameliorates high glucose-induced cardiomyocytes injury via AMPK/mTOR signal pathway. Cell biology international 44 (11) (2020)